SCHEMBL20525840

SCHEMBL20525840

COc1c(OCC2CCNCC2)ccc2c(Oc3ccc(NC(=O)C(=O)NCCc4ccccc4C)cc3F)ccnc12

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 16/20 0.49
FLT3 P36888 3/20 0.40
IGF1R P08069 3/20 0.37
KDR P35968 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525793 0.95 MET (0.50) METFLT3IGF1RKDR
SCHEMBL20525743 0.94 MET (0.51) METFLT3KDR
SCHEMBL20525785 0.94 MET (0.49) METFLT3IGF1RKDR
SCHEMBL20525602 0.93 MET (0.46) METFLT3KDR
SCHEMBL20525706 0.93 MET (0.48) METFLT3IGF1RKDR
SCHEMBL20525853 0.93 MET (0.48) METFLT3IGF1RKDR
SCHEMBL20525709 0.93 MET (0.46) METFLT3KDR
SCHEMBL20525596 0.92 MET (0.48) METFLT3KDR
SCHEMBL20525613 0.92 MET (0.48) METFLT3KDR
SCHEMBL20525585 0.91 MET (0.52) METFLT3IGF1RKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed